
Pharma News
-
A batch of new posts in the field of health will be created
2019-09-10Speeding up the development of geriatric care services is an important part of actively responding to the aging population and an objective requirement of implementing the strategy of healthy China.
-
Dehumidifier for early autumn joints
2019-09-05After autumn, the accumulated summer heat and dampness still remain in the body, the most common of which is the joint disease caused by dampness.
-
Baotou seized a serious illegal pharmacy
2019-09-05The law enforcement officers immediately report the case to the local public security organs and transfer the case to the public security organs for investigation.
-
New methods can destroy the 'protective wall' of cancer cells
2019-09-05According to a study published by Birmingham University on August 26, researchers have found a new way to destroy the "protective wall" around cancer cells, thereby effectively killing cancer cells.
-
Guinea plans to drastically reduce the number of drug importers to four
2019-09-02Guinean media Guineematin.com recently reported that the Guinean government plans to reduce the number of drug importers by a large margin, with the ultimate goal of reducing the number to four.
-
Arrhythmia of second-born mothers who lose weight and exercise for 2 hours a day
2019-08-30After giving birth to a second child, women are anxious to lose weight. Therefore, they work hard for two to three hours in the gym every day.
-
The overall initiation rate of the evaluation in the generic drug was 11.18%
2019-08-29After the time limit for consistency evaluation was cancelled at the end of last year, the consistency evaluation of generic drugs involving 4185 varieties is still accelerating.
-
From January to March 2019, China's imports of pharmaceuticals fell by 6.6%
2019-08-29According to the database of China Business Industry Research Institute, China's imports of pharmaceuticals increased moderately from 2015 to 2018, and from January to March 2019, China's imports of pharmaceuticals decreased by 6.6%.
-
China's exports of pharmaceuticals increased by 6.3% year on year
2019-08-29According to the database of China Business Industry Research Institute, China's pharmaceutical exports grew moderately from January to March 2019 and from 2013 to 2018, with a total increase of 26.18%.
-
Shaanxi Province will implement remote service instead of licensed pharmacists
2019-08-29From August 22 to September 16, Shaanxi Province has implemented remote service instead of on-the-job licensed pharmacists in stores.
-
What and how should regular cancer prevention check-ups be conducted?
2019-08-26The Health China Action (2019-2030), issued recently in China, aims to basically realize that high-risk groups of cancer participate in regular cancer prevention physical examination.
-
More than 100 companies reported better-than-expected results in pharma
2019-08-26Under the background of frequent "thunderstorms" in Baima stock market, companies whose performance exceeded expectations by a large margin aroused market attention.
-
Flow Cytometry Market: Local Enterprises Have Great Prospects
2019-08-26Flow cytometry (FCM) is a rapid multi-parameter quantitative analysis and sorting technique for cells or other biological particles (e.g. bacteria) in fluid flow.
-
China's drug terminal market sold 908.7 billion yuan in the first half
2019-08-26In the first half of 2019, the sales of Chinese drug terminal market increased by 5.8% to 908.7 billion yuan, while in the first half of 2018, the sales of Chinese drug terminal market increased by 6.9% to 859 billion yuan.
-
Hebei liberalizes the scope of practicing traditional Chinese medicine
2019-08-26The province clearly states that non-traditional Chinese medicine practitioners have one of the four situations in which they can provide Chinese medicine services.
-
The more anemia the elderly get, the more they are diagnosed with colon cancer.
2019-08-22On August 13, Changsha Evening News reported that Xiang Bingyun, 66, had moderate anemia. After insisting on eating a large amount of blood-tonifying food, the anemia became more and more serious.
-
Experts warn that the prevention of cervical spondylosis should start
2019-08-19Dizziness, headache, arm pain, shoulder sinking, hand numbness, deafness and tinnitus, visual impairment, memory loss... These symptoms, most likely caused by the same disease, are cervical spondylosis.
-
Sixteen applications for drug registration are to be included in the review
2019-08-19The Drug Review Center of the State Drug Administration announced 16 priority evaluation varieties, including 8 rare disease treatment drugs such as human prothrombin complex.
-
A panoramic analysis of traditional Chinese medicine injection
2019-08-16In China's drug market, besides chemicals, there are also proprietary Chinese medicines with Chinese characteristics.
-
FDA approved olapanib for first-line treatment of ovarian cancer
2019-08-16PMLiVE reported on December 19 that AstraZeneca's Lynparza became the first PARP inhibitor approved for the first-line maintenance treatment of BRCA mutated ovarian cancer.
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan